Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL).

V Kunzmann, K Kelm, S Eckstein, Martin Wilhelm

Universitätsklinik für Innere Medizin 5 - Onkologie und Hämatologie

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	733A-733A
Fachzeitschrift	BLOOD
Jahrgang	96
Ausgabenummer	11
Publikationsstatus	Veröffentlicht - 2000

Dieses zitieren

Kunzmann, V., Kelm, K., Eckstein, S., & Wilhelm, M. (2000). Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL). BLOOD , 96(11), 733A-733A.

Kunzmann, V ; Kelm, K ; Eckstein, S et al. / Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL). in: BLOOD 2000 ; Jahrgang 96, Nr. 11. S. 733A-733A.

@article{abcabd9a33a84c3fa06936f4b6729b00,

title = "Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL).",

author = "V Kunzmann and K Kelm and S Eckstein and Martin Wilhelm",

year = "2000",

language = "English",

volume = "96",

pages = "733A--733A",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "11",

}

Kunzmann, V, Kelm, K, Eckstein, S & Wilhelm, M 2000, 'Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL).', BLOOD , Jg. 96, Nr. 11, S. 733A-733A.

Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL). / Kunzmann, V; Kelm, K; Eckstein, S et al.
in: BLOOD , Jahrgang 96, Nr. 11, 2000, S. 733A-733A.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL).

AU - Kunzmann, V

AU - Kelm, K

AU - Eckstein, S

AU - Wilhelm, Martin

PY - 2000

Y1 - 2000

M3 - Abstract (Journal)

SN - 0006-4971

VL - 96

SP - 733A-733A

JO - BLOOD

JF - BLOOD

IS - 11

ER -

Kunzmann V, Kelm K, Eckstein S, Wilhelm M. Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL). BLOOD . 2000;96(11):733A-733A.